Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval Generative AI Industry IP Enforcement and CrossBorder Competitive Developments Is Universal UHS stock losing upward strength Universal posts 13 EPS miss vs analyst forecast